It looks like nothing was found at this location. Maybe try one of the links below or a search?
Recent Posts
- Cellestia awarded Innosuisse Grant to advance GvHD prevention therapy
- Cellestia’s publication “The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer” is out in Cancers
- A new IIT Phase II trial is now open for patient recruitment at Dana-Farber Cancer Institute
- The Investigator Initiated Phase II Trial at MD Anderson Cancer Center combining CB-103 and Venetoclax for the treatment of rr/r-T-ALL patients is now open for recruitment
- CB-103 treatment in metastatic clear cell renal cell carcinoma shows promising results
Most Used Categories
- News (16)
- 2021 (10)
- Publications (9)
- Press releases (8)
- 2020 (7)
- 2019 (6)
- 2023 (4)
- 2022 (1)
- 2024 (1)
Archives
Try looking in the monthly archives. 🙂